Go Pro

Empowered Funds LLC Makes New Investment in Xylem Inc. $XYL

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Empowered Funds LLC initiated a 108,789-share position in Xylem during the second quarter, valued at approximately $12.86 million. Institutional investors collectively own 87.96% of the company.
  • Xylem exceeded quarterly earnings expectations, reporting $1.46 in EPS versus the $1.34 consensus estimate, while revenue rose 1.5% year over year to $2.34 billion.
  • Analysts maintain a “Moderate Buy” consensus with an average price target of $155, substantially above the stock’s reported $111.44 price; Xylem also declared a $0.43 quarterly dividend, yielding about 1.5% annually.
  • MarketBeat previews top five stocks to own in September.

Empowered Funds LLC purchased a new stake in shares of Xylem Inc. (NYSE:XYL - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 108,789 shares of the industrial products company's stock, valued at approximately $12,860,000.

Several other large investors have also recently modified their holdings of XYL. AQR Capital Management LLC grew its position in Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company's stock worth $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC lifted its position in Xylem by 3.3% in the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company's stock valued at $496,000 after purchasing an additional 132 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Xylem by 97.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company's stock valued at $1,442,000 after purchasing an additional 5,509 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Xylem by 114.0% during the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company's stock valued at $154,000 after purchasing an additional 635 shares during the period. Finally, Jump Financial LLC bought a new position in shares of Xylem in the second quarter worth approximately $2,041,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Stock Performance

Shares of XYL stock opened at $111.44 on Friday. The stock has a fifty day moving average of $118.20 and a 200 day moving average of $118.87. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The firm has a market capitalization of $26.02 billion, a price-to-earnings ratio of 26.53, a PEG ratio of 1.66 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same period in the previous year, the firm earned $1.26 EPS. The company's quarterly revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, research analysts expect that Xylem Inc. will post 5.66 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be given a dividend of $0.43 per share. The ex-dividend date is Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem's payout ratio is currently 40.95%.

Wall Street Analyst Weigh In

A number of research firms recently commented on XYL. Mizuho upped their price target on shares of Xylem from $124.00 to $130.00 and gave the company a "neutral" rating in a report on Wednesday, July 29th. Royal Bank Of Canada raised their price target on shares of Xylem from $159.00 to $164.00 and gave the stock an "outperform" rating in a report on Wednesday, July 29th. Stifel Nicolaus boosted their price objective on shares of Xylem from $157.00 to $160.00 and gave the company a "buy" rating in a research report on Wednesday, July 29th. Barclays upped their price objective on shares of Xylem from $154.00 to $159.00 and gave the company an "overweight" rating in a research note on Wednesday, July 29th. Finally, Citigroup reissued a "buy" rating on shares of Xylem in a research note on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $155.00.

Read Our Latest Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines